COH04S1

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameCOH04S1
Drug Alias NameGEO/COH04S1SARS-CoV-2 vaccine COH04S1sMVA-based SARS-CoV-2 vaccine COH04S1COH-04-S-1COH-04S1 +[7] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Hematologic NeoplasmsMultiple Myeloma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesGeovax Inc
Inactive CompaniesCity Of Hope National Medical Center
Active IndicationsCoronavirus Disease 2019 (COVID-19)Hematologic NeoplasmsMultiple Myeloma +[5] 
Inactive IndicationsLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A